BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16898255)

  • 1. Neuropathy and Fabry disease: pathogenesis and enzyme replacement therapy.
    Schiffmann R
    Acta Neurol Belg; 2006 Jun; 106(2):61-5. PubMed ID: 16898255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease.
    Schiffmann R; Floeter MK; Dambrosia JM; Gupta S; Moore DF; Sharabi Y; Khurana RK; Brady RO
    Muscle Nerve; 2003 Dec; 28(6):703-10. PubMed ID: 14639584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on Fabry disease: kidney involvement, renal progression and enzyme replacement therapy.
    Breunig F; Wanner C
    J Nephrol; 2008; 21(1):32-7. PubMed ID: 18264934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurological complications of Fabry-disease].
    Vastagh I; Constantin T; Kéri A; Rudas G; Fekete G; Bereczki D
    Ideggyogy Sz; 2011 Jan; 64(1-2):29-35. PubMed ID: 21428036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small fibers in Fabry disease: baseline and follow-up data under enzyme replacement therapy.
    Üçeyler N; He L; Schönfeld D; Kahn AK; Reiners K; Hilz MJ; Breunig F; Sommer C
    J Peripher Nerv Syst; 2011 Dec; 16(4):304-14. PubMed ID: 22176145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and structural nerve fiber findings in heterozygote patients with Fabry disease.
    Torvin Møller A; Winther Bach F; Feldt-Rasmussen U; Rasmussen A; Hasholt L; Lan H; Sommer C; Kølvraa S; Ballegaard M; Staehelin Jensen T
    Pain; 2009 Sep; 145(1-2):237-45. PubMed ID: 19665302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabry disease.
    Toyooka K
    Curr Opin Neurol; 2011 Oct; 24(5):463-8. PubMed ID: 21825987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabry disease.
    Toyooka K
    Handb Clin Neurol; 2013; 115():629-42. PubMed ID: 23931807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme replacement therapy improves function of C-, Adelta-, and Abeta-nerve fibers in Fabry neuropathy.
    Hilz MJ; Brys M; Marthol H; Stemper B; Dütsch M
    Neurology; 2004 Apr; 62(7):1066-72. PubMed ID: 15079003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological complications in Fabry disease.
    Dütsch M; Hilz MJ
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S243-50. PubMed ID: 21211673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological features of Fabry disease: clinical, pathophysiological aspects and therapy.
    Bersano A; Lanfranconi S; Valcarenghi C; Bresolin N; Micieli G; Baron P
    Acta Neurol Scand; 2012 Aug; 126(2):77-97. PubMed ID: 22428782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peripheral neuropathy in Anderson-Fabry disease: its physiology, evaluation and treatment].
    Politei JM; Pagano MA
    Rev Neurol; 2004 May 16-31; 38(10):979-83. PubMed ID: 15175982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabry disease: clinical spectrum and evidence-based enzyme replacement therapy.
    Desnick RJ; Banikazemi M
    Nephrol Ther; 2006 Jan; 2 Suppl 2():S172-85. PubMed ID: 17373219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurophysiological, behavioral and morphological abnormalities in the Fabry knockout mice.
    Rodrigues LG; Ferraz MJ; Rodrigues D; Pais-Vieira M; Lima D; Brady RO; Sousa MM; Sá-Miranda MC
    Neurobiol Dis; 2009 Jan; 33(1):48-56. PubMed ID: 18848893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal confocal microscopy: a novel noninvasive means to diagnose neuropathy in patients with Fabry disease.
    Tavakoli M; Marshall A; Thompson L; Kenny M; Waldek S; Efron N; Malik RA
    Muscle Nerve; 2009 Dec; 40(6):976-84. PubMed ID: 19902546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropathic symptoms and findings in women with Fabry disease.
    Laaksonen SM; Röyttä M; Jääskeläinen SK; Kantola I; Penttinen M; Falck B
    Clin Neurophysiol; 2008 Jun; 119(6):1365-72. PubMed ID: 18387337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autonomic skin responses in females with Fabry disease.
    Møller AT; Bach FW; Feldt-Rasmussen U; Rasmussen AK; Hasholt L; Sommer C; Kølvraa S; Jensen TS
    J Peripher Nerv Syst; 2009 Sep; 14(3):159-64. PubMed ID: 19909479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fabry disease.
    Schiffmann R
    Pharmacol Ther; 2009 Apr; 122(1):65-77. PubMed ID: 19318041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small fiber neuropathy in female patients with fabry disease.
    Liguori R; Di Stasi V; Bugiardini E; Mignani R; Burlina A; Borsini W; Baruzzi A; Montagna P; Donadio V
    Muscle Nerve; 2010 Mar; 41(3):409-12. PubMed ID: 20120004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystatin C as a marker of early changes of renal function in Fabry nephropathy.
    Feriozzi S; Germain DP; Di Vito R; Legrand A; Ricci R; Barbey F
    J Nephrol; 2007; 20(4):437-43. PubMed ID: 17879210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.